Source: StreetInsider

Press Release: Accuron Technologies : Dornier MedTech Launches the DORNIER DELTA® III - Most Advanced Kidney Stone Treatment Lithotripter

Dornier MedTech® America, a global medical device company and the pioneer of Extracorporeal Shock Wave Lithotripsy (ESWL®), has received FDA clearance to market the Delta® III. This is the latest generation of the world's best-selling and most clinically cited lithotripter, the Delta II.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
10-50K
Tan Kai Hoe's photo - President & CEO of Accuron

President & CEO

Tan Kai Hoe

CEO Approval Rating

74/100

Read more